Patent: 10,557,862

Summary for Patent: 10,557,862

Title:	Systems for assuring quality compliance of point-of-care single-use testing devices
Abstract:	The present invention relates to systems and methods of determining quality compliance for a set of biological sample testing devices used with one or more test instruments at the point-of-care in a hospital or other location that delivers medical care. In particular, the systems and methods ensure that only biological sample testing devices that pass a quality assurance protocol are used for point-of-care testing.
Inventor(s):	Glavina; Paul (Kanata, CA), Tirinato; Jody Ann (Plainsboro, NJ)
Assignee:	Abbott Point of Care Inc. (Princeton, NJ)
Application Number:	15/145,934
Patent Claims:	see list of patent claims

Details for Patent 10,557,862

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	January 15, 1974	10,557,862	2036-05-04
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	December 27, 1984	10,557,862	2036-05-04
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	February 15, 1985	10,557,862	2036-05-04
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	February 16, 1990	10,557,862	2036-05-04
Bel-mar Laboratories, Inc.	CHORIONIC GONADOTROPIN	chorionic gonadotropin	Injection	017054	March 26, 1974	10,557,862	2036-05-04
Ferring Pharmaceuticals Inc.	A.P.L.	chorionic gonadotropin	For Injection	017055	December 13, 1974	10,557,862	2036-05-04
Fresenius Kabi Usa, Llc	CHORIONIC GONADOTROPIN	chorionic gonadotropin	For Injection	017067	March 05, 1973	10,557,862	2036-05-04